Free Trial
NASDAQ:BMGL

Basel Medical Group (BMGL) Stock Price, News & Analysis

Basel Medical Group logo
$3.46 -1.24 (-26.38%)
As of 06/13/2025 04:00 PM Eastern

About Basel Medical Group Stock (NASDAQ:BMGL)

Key Stats

Today's Range
$2.93
$4.85
50-Day Range
$1.02
$5.09
52-Week Range
$0.91
$9.40
Volume
2.55 million shs
Average Volume
4.55 million shs
Market Capitalization
$63.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Receive BMGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Basel Medical Group and its competitors with MarketBeat's FREE daily newsletter.

BMGL Stock News Headlines

Basel Medical Group Ltd.
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
BMGL Basel Medical Group Ltd
Basel Medical Group Ltd (BMGL)
See More Headlines

BMGL Stock Analysis - Frequently Asked Questions

Basel Medical Group's stock was trading at $4.50 at the beginning of the year. Since then, BMGL stock has decreased by 23.1% and is now trading at $3.46.
View the best growth stocks for 2025 here
.

Basel Medical Group (BMGL) raised $9 million in an initial public offering (IPO) on Tuesday, February 25th 2025. The company issued 2,205,000 shares at a price of $4.00 per share.

Basel Medical Group's lock-up period expires on Monday, August 25th. Basel Medical Group had issued 2,205,000 shares in its initial public offering on February 25th. The total size of the offering was $8,820,000 based on an initial share price of $4.00. After the end of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Services
Industry
Services – Health
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BMGL
Web
N/A
Fax
N/A
Employees
36
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.05 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$63.85 million
Optionable
N/A
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:BMGL) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners